FTO analysis*
Formulation
IP filling
Clinical/BA/BE
Dossier
|
|
| Product |
Indication |
FTO analysis* |
Formulation |
IP filling |
Clinical/BA/BE |
Dossier |
Registration |
Partner |
|
|
|
|
|
|
|
|
|
|
A synergistic API combination
|
Ischemic heart disease |
|
|
|
|
|
|
Emona Biopharma |
|
Pirfenidone
|
Idiopathic pulmonary fibrosis |
|
|
|
|
|
|
Zenvision Pharma |
|
Brivaracetam
|
Epilepsy |
|
|
|
|
|
|
Zenvision Pharma |
|
Colchicine
|
Gout |
|
|
|
|
|
|
Zenvision Pharma |
|
Olopatadine-Nepafenac
|
Ophthalmic disorders |
|
|
|
|
|
|
Zenvision Pharma |
|
Triamcinolone acetonide
|
Skin disorders |
|
|
|
|
|
|
Zenvision Pharma |
|
Nintedanib
|
Idiopathic pulmonary fibrosis |
|
|
|
|
|
|
Zenvision Pharma |
|
Miconazole-Luliconazole
|
Vaginal infections |
|
|
|
|
|
|
Zenvision Pharma |
|
Obeticholic Acid
|
Primary Biliary Cholangitis |
|
|
|
|
|
|
Zenvision Pharma |
|
Antifungal Cuticle Oil platform
|
Fungal infections |
|
|
|
|
|
|
Zenvision Pharma |
|
Synergistic Nutraceutical combo
|
Epilepsy |
|
|
|
|
|
|
Zenvision Pharma |
*KSM performs bigdata driven whitespace analysis using ‘fish net’ principle to identify areas of unmet need to guide product development and positioning
